LoadingLoadingLoading30 funds hold it.Insiders net selling.
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 4, 2026
Period ending
Oct 4, 2026
Earnings per share
$0.52 expected
Estimates as of Nov 9, 2026
EPS expected
$0.34 to $0.50
Revenue expected
16 analysts
Last 30 days
Split both ways
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Oct 4, 2026Reported Nov 4, 2026 | $0.53est. $0.52 | +1.98%beat | $313.4MSEC filing | +13.2%from $276.9M |
| Jul 5, 2026Reported Aug 5, 2026 | $0.45est. $0.42 | +5.93%beat | $291.3MSEC filing | +16.9%from $249.1M |
| Apr 5, 2026Reported May 6, 2026 | $0.34est. $0.25 | +37.07%beat | $268.4MSEC filing | +24.3%from $216.0M |
| Dec 31, 2025Reported Feb 11, 2026 | $0.27est. $0.22 | +22.94%beat | $252.3MAlpha Vantage | +9.9%from $229.7M |
| Sep 28, 2025Reported Oct 29, 2025 | $0.33est. $0.29 | +13.79%beat | $276.9MSEC filing | +18.0%from $234.7M |
| Jun 29, 2025Reported Jul 30, 2025 | $0.25est. $0.24 | +4.17%beat | $249.1MSEC filing | +4.1%from $239.3M |
| Mar 30, 2025Reported Apr 30, 2025 | $0.16est. $0.13 | +23.08%beat | $216.0MSEC filing | +2.5%from $210.8M |
| Dec 31, 2024Reported Feb 12, 2025 | $0.20est. $0.16 | +25.00%beat | $229.7MAlpha Vantage | +16.8%from $196.7M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $252.3M | $268.4M | $291.3M | $313.4M |
| Cost of what it sold | $86.4M | $77.5M | $85.5M | $91.6M |
| Gross profit | $165.9M | $190.9M | $205.8M | $221.7M |
| What it spent | ||||
| Research and development | $36.1M | $37.0M | $32.4M | $33.9M |
| Sales and admin | $94.6M | $94.0M | $87.9M | $87.0M |
| Total operating expenses | $130.6M | $131.1M | $120.3M | $120.9M |
| What was left | ||||
| Operating profit | $35.3M | $59.9M | $85.5M | $100.8M |
| Profit before tax | $44.1M | $61.8M | $89.3M | $103.3M |
| Tax | $11.4M | $10.1M | $16.5M | $18.5M |
| Net profit | $32.7M | $51.7M | $72.8M | $84.8M |
| EBITDA | $51.4M | $69.0M | $88.6M | $103.3M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
12 macro signals shaping CGNX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
